skip to content

Cambridge Cardiovascular

 
Read more at: Heart surgery delays will cost lives, warns research

Heart surgery delays will cost lives, warns research

17 June 2022

Urgent action is needed to clear the backlog of people with a common heart condition who are waiting for lifesaving treatment, according to research supported by the British Heart Foundation published today in BMJ Open 1 . The researchers have warned that a lack of action could result in thousands of people dying while...


Read more at: New paper in Nature Metabolism. Congratulations to Dr Vanessa Pellegrinelli and Toni Vidal-Puig Lab and all collaborators.

New paper in Nature Metabolism. Congratulations to Dr Vanessa Pellegrinelli and Toni Vidal-Puig Lab and all collaborators.

26 April 2022

Dysregulation of macrophage PEPD in obesity determines adipose tissue fibro-inflammation and insulin resistance


Read more at: Molecular messenger reveals new treatment pathway for COVID-19

Molecular messenger reveals new treatment pathway for COVID-19

7 April 2022

St Catharine’s researchers are part of a team from the University of Cambridge, Addenbrooke’s and Royal Papworth hospitals, and AstraZeneca who have discovered a new pathway for treating COVID-19 infections after studying the blood plasma of patients hospitalised during the first wave of the pandemic. The virus causing...


Read more at: Stephen Hider's BHF fundraising run

Stephen Hider's BHF fundraising run

7 April 2022

Stephen Hider, a local Cambridgeshire man, is running a marathon a day for 35 days in memory of his young niece who died from a heart condition. Stephen will be running from/to the new Heart Lung Research Institute on 11 April. LINK to article click heading


Read more at: Potential Therapeutic Target Found for Rare Blood Disorder

Potential Therapeutic Target Found for Rare Blood Disorder

3 February 2022

Researchers have identified a new therapeutic target that could be critical in developing improved treatments for thrombcythaemia. Read more..click link above


Read more at: Hope for new heart attack treatment targeting dangerous immune response

Hope for new heart attack treatment targeting dangerous immune response

2 February 2022

A cancer drug could harness the power of the immune system to improve recovery after a heart attack and has the potential to become the first treatment of its kind available for patients ...Read more


Read more at: Heart Research UK grant for University of Cambridge’s Prof Ziad Mallat will investigate route to tackling leading cause of death globally

Heart Research UK grant for University of Cambridge’s Prof Ziad Mallat will investigate route to tackling leading cause of death globally

14 January 2022

A research grant of £190,000 will help the University of Cambridge’s Professor Ziad Mallat investigate a potential route towards a new treatment for the leading cause of death globally. Read more click link above


Read more at: Britons suffering heart failure could be cured with patches of cells

Britons suffering heart failure could be cured with patches of cells

6 January 2022

Britons suffering heart failure could be cured with patches of cells ...Read article here


Read more at: Europe’s largest heart and lung research centre for Royal Papworth Hospital and University of Cambridge moves step closer

Europe’s largest heart and lung research centre for Royal Papworth Hospital and University of Cambridge moves step closer

17 December 2021

The Heart and Lung Research Institute (HLRI) is a joint initiative between the University of Cambridge and Royal Papworth Hospital NHS Foundation Trust. Read More...


Read more at: A big first step in our strategy to test low-dose IL-2 as a potential treatment for patients with ischemic heart disease

A big first step in our strategy to test low-dose IL-2 as a potential treatment for patients with ischemic heart disease

30 November 2021

Congratulations Tian Zhao, Ziad Mallat and all the collaborators . More on our approach from the bench to the bedside just published in NEJM Evidence. Click the link to see the article ' Regulatory T-Cell Response to Low-Dose Interleukin- 2 2 in Ischemic Heart Disease '


Cambridge Cardiovascular logo - transparent

Logo design by Dr Ana-Mishel Spiroski and Dr Sarah Morgan.

 

We connect cardiovascular researchers in Cambridge.

Please follow us on Twitter for local news about research, events, funding calls, and open positions.

For inquiries about our research or the website, please contact Dr Tammy Dougan

Events Coming Up

Cambridge Cardiovascular on You Tube

Follow us on Twitter